| scholarly article | Q13442814 |
| P50 | author | Jeffrey A. Hubbell | Q42863795 |
| P2093 | author name string | Jennifer R Cochran | |
| Priscilla S Briquez | |||
| Aaron C Mitchell | |||
| P2860 | cites work | Engineered epidermal growth factor mutants with faster binding on-rates correlate with enhanced receptor activation | Q24298119 |
| DNA shuffling by random fragmentation and reassembly: in vitro recombination for molecular evolution | Q24562755 | ||
| Engineered SIRPα variants as immunotherapeutic adjuvants to anticancer antibodies | Q24605057 | ||
| Extracellular Matrix-Inspired Growth Factor Delivery Systems for Skin Wound Healing | Q26798452 | ||
| Fibroblast growth factors, their receptors and signaling | Q28140520 | ||
| Regulation of wound healing by growth factors and cytokines | Q29615242 | ||
| The extracellular matrix: not just pretty fibrils | Q29617251 | ||
| Functions of cell surface heparan sulfate proteoglycans | Q29618521 | ||
| Heparin-II domain of fibronectin is a vascular endothelial growth factor-binding domain: enhancement of VEGF biological activity by a singular growth factor/matrix protein synergism | Q30504482 | ||
| Growth factor engineering by degenerate homoduplex gene family recombination | Q30869925 | ||
| Characterization of growth factor-binding structures in heparin/heparan sulfate using an octasaccharide library | Q33196496 | ||
| Improved mutants from directed evolution are biased to orthologous substitutions | Q33245427 | ||
| Optimizing the affinity and specificity of proteins with molecular display | Q33252425 | ||
| Selecting high-affinity binding proteins by monovalent phage display | Q33421871 | ||
| Extracellular matrix, inflammation, and the angiogenic response | Q33795730 | ||
| Controlled release of nerve growth factor from a heparin-containing fibrin-based cell ingrowth matrix | Q33920258 | ||
| Engineering hepatocyte growth factor fragments with high stability and activity as Met receptor agonists and antagonists | Q33970874 | ||
| Discovery of improved EGF agonists using a novel in vitro screening platform | Q34010302 | ||
| Extracellular matrix and cytokines: a functional unit. | Q34092908 | ||
| Extracellular matrix and cell signalling: the dynamic cooperation of integrin, proteoglycan and growth factor receptor. | Q34163575 | ||
| The effects of processing methods upon mechanical and biologic properties of porcine dermal extracellular matrix scaffolds. | Q34206290 | ||
| Intraarticular injection of heparin-binding insulin-like growth factor 1 sustains delivery of insulin-like growth factor 1 to cartilage through binding to chondroitin sulfate | Q34367377 | ||
| An engineered Axl 'decoy receptor' effectively silences the Gas6-Axl signaling axis | Q34439798 | ||
| Gelatin as a delivery vehicle for the controlled release of bioactive molecules | Q34464776 | ||
| Decellularization of tissues and organs. | Q34499965 | ||
| Design of growth factor sequestering biomaterials | Q34543371 | ||
| Growth factor delivery-based tissue engineering: general approaches and a review of recent developments | Q34548765 | ||
| A simple luciferase assay for signal transduction activity detection of epidermal growth factor displayed on phage | Q34627463 | ||
| Tenascin C promiscuously binds growth factors via its fifth fibronectin type III-like domain. | Q34700906 | ||
| Structural specificity of heparin binding in the fibroblast growth factor family of proteins | Q34805392 | ||
| Experimental assessment of pro-lymphangiogenic growth factors in the treatment of post-surgical lymphedema following lymphadenectomy | Q34989014 | ||
| The effect of collagen-binding NGF-beta on the promotion of sciatic nerve regeneration in a rat sciatic nerve crush injury model. | Q34990370 | ||
| Delivery of an engineered HGF fragment in an extracellular matrix-derived hydrogel prevents negative LV remodeling post-myocardial infarction | Q35078379 | ||
| Biopolymeric delivery matrices for angiogenic growth factors. | Q35589939 | ||
| Wound healing: the role of growth factors | Q35605495 | ||
| Growth factors and chronic wound healing: past, present, and future | Q35643263 | ||
| Comparison between heparin-conjugated fibrin and collagen sponge as bone morphogenetic protein-2 carriers for bone regeneration | Q36005075 | ||
| Injectable extracellular matrix derived hydrogel provides a platform for enhanced retention and delivery of a heparin-binding growth factor | Q36194967 | ||
| Understanding cytokine and growth factor receptor activation mechanisms | Q36509470 | ||
| Heparin-binding domain of fibrin(ogen) binds growth factors and promotes tissue repair when incorporated within a synthetic matrix | Q36712745 | ||
| Epidermal growth factor and transforming growth factor-alpha: differential intracellular routing and processing of ligand-receptor complexes | Q36745372 | ||
| An approach to random mutagenesis of DNA using mixtures of triphosphate derivatives of nucleoside analogues | Q36791806 | ||
| Growth factor binding to the pericellular matrix and its importance in tissue engineering | Q36960700 | ||
| Complications due to the use of BMP/INFUSE in spine surgery: The evidence continues to mount | Q37030161 | ||
| Interactions between extracellular matrix and growth factors in wound healing | Q37423377 | ||
| Sustained release of epidermal growth factor accelerates wound repair | Q37553642 | ||
| Binding to the extracellular matrix and proteolytic processing: two key mechanisms regulating vascular endothelial growth factor action | Q37698859 | ||
| MET signalling: principles and functions in development, organ regeneration and cancer | Q37811895 | ||
| Organ engineering based on decellularized matrix scaffolds | Q37868162 | ||
| Joseph Rudinger memorial lecture: discovery and applications of cyclotides | Q38112084 | ||
| Growth factor conjugation: strategies and applications | Q38204731 | ||
| Biomaterials for tissue engineering applications | Q38226229 | ||
| Heparin is required for cell-free binding of basic fibroblast growth factor to a soluble receptor and for mitogenesis in whole cells | Q38331586 | ||
| Extracellular matrix-inspired growth factor delivery systems for bone regeneration | Q38431316 | ||
| Semi-synthesis of a HGF/SF kringle one (K1) domain scaffold generates a potent in vivo MET receptor agonist. | Q38674666 | ||
| Hyaluronic acid: evaluation as a potential delivery vehicle for vitronectin:growth factor complexes in wound healing applications | Q39566220 | ||
| Scaffolds with covalently immobilized VEGF and Angiopoietin-1 for vascularization of engineered tissues | Q39791944 | ||
| Enzymatic formation of modular cell-instructive fibrin analogs for tissue engineering. | Q40119869 | ||
| Construction of a novel extracellular matrix using a new genetically engineered epidermal growth factor fused to IgG-Fc | Q40358686 | ||
| Growth hormone binding affinity for its receptor surpasses the requirements for cellular activity | Q40980116 | ||
| Purification and analysis of proteinase-resistant mutants of recombinant platelet-derived growth factor-BB exhibiting improved biological activity | Q42031020 | ||
| An engineered dimeric fragment of hepatocyte growth factor is a potent c-MET agonist | Q42088207 | ||
| Ligand-induced lysosomal epidermal growth factor receptor (EGFR) degradation is preceded by proteasome-dependent EGFR de-ubiquitination | Q42800213 | ||
| Superagonistic activation of ErbB-1 by EGF-related growth factors with enhanced association and dissociation rate constants | Q42801170 | ||
| Engineering epidermal growth factor for enhanced mitogenic potency | Q42806339 | ||
| Enhancement of epidermal regeneration by biosynthetic epidermal growth factor | Q42938012 | ||
| Functional and biophysical characterization of recombinant human hepatocyte growth factor isoforms produced in Escherichia coli | Q42987814 | ||
| Rational cytokine design for increased lifetime and enhanced potency using pH-activated "histidine switching". | Q44089221 | ||
| FGF-2 but not FGF-1 binds fibrin and supports prolonged endothelial cell growth | Q44518780 | ||
| Mimicking the Escherichia coli cytoplasmic environment activates long-lived and efficient cell-free protein synthesis | Q44791208 | ||
| Mathematical model of human growth hormone (hGH)-stimulated cell proliferation explains the efficacy of hGH variants as receptor agonists or antagonists | Q44860854 | ||
| Cell-demanded liberation of VEGF121 from fibrin implants induces local and controlled blood vessel growth | Q47882147 | ||
| A brief definition of regenerative medicine | Q48012344 | ||
| Linear ordered collagen scaffolds loaded with collagen-binding brain-derived neurotrophic factor improve the recovery of spinal cord injury in rats | Q48703263 | ||
| Matrix-bound growth factors in tissue repair. | Q51162232 | ||
| Enhanced bone regeneration at a segmental bone defect by controlled release of bone morphogenetic protein-2 from a biodegradable hydrogel. | Q51181570 | ||
| Regeneration of canine tracheal cartilage by slow release of basic fibroblast growth factor from gelatin sponge. | Q51282047 | ||
| Endothelial cell proliferation and progenitor maturation by fibrin-bound VEGF variants with differential susceptibilities to local cellular activity. | Q51569295 | ||
| Collagen scaffolds loaded with collagen-binding NGF-beta accelerate ulcer healing. | Q51770845 | ||
| Overproduction of recombinant human hepatocyte growth factor in Chinese hamster ovary cells. | Q51776834 | ||
| Protein engineered variants of hepatocyte growth factor/scatter factor promote proliferation of primary human hepatocytes and in rodent liver. | Q53198173 | ||
| Growth Factors Engineered for Super-Affinity to the Extracellular Matrix Enhance Tissue Healing | Q53527947 | ||
| Engineering the Growth Factor Microenvironment with Fibronectin Domains to Promote Wound and Bone Tissue Healing | Q53528097 | ||
| Collagens in the liver extracellular matrix bind hepatocyte growth factor. | Q53961028 | ||
| Yeast polypeptide fusion surface display levels predict thermal stability and soluble secretion efficiency | Q56902099 | ||
| Vitronectin: Growth Factor Complexes Hold Potential as a Wound Therapy Approach | Q59262311 | ||
| Intracellular trafficking of epidermal growth factor family ligands is directly influenced by the pH sensitivity of the receptor/ligand interaction | Q72591875 | ||
| VEGF145, a secreted vascular endothelial growth factor isoform that binds to extracellular matrix | Q73119438 | ||
| Vascular endothelial growth factor binds to fibrinogen and fibrin and stimulates endothelial cell proliferation | Q73219902 | ||
| Engineered insulin-like growth factor-1 for improved smooth muscle regeneration | Q82119592 | ||
| The 12th-14th type III repeats of fibronectin function as a highly promiscuous growth factor-binding domain | Q84617570 | ||
| Human pilot studies reveal the potential of a vitronectin: growth factor complex as a treatment for chronic wounds | Q95386102 | ||
| P921 | main subject | regenerative medicine | Q1061415 |
| P304 | page(s) | 1-12 | |
| P577 | publication date | 2015-11-07 | |
| P1433 | published in | Acta Biomaterialia | Q4676719 |
| P1476 | title | Engineering growth factors for regenerative medicine applications | |
| P478 | volume | 30 |
| Q50865119 | * Programmed Platelet-Derived Growth Factor-BB and Bone Morphogenetic Protein-2 Delivery from a Hybrid Calcium Phosphate/Alginate Scaffold. |
| Q47593320 | 3D Bioprinting for Organ Regeneration |
| Q89619546 | 3D Printed Neural Regeneration Devices |
| Q51264763 | A Bioorthogonal Approach for the Preparation of a Titanium-Binding Insulin-like Growth-Factor-1 Derivative by Using Tyrosinase. |
| Q91745248 | A chemically unmodified agonistic DNA with growth factor functionality for in vivo therapeutic application |
| Q91893632 | Better growth-factor binding aids tissue repair |
| Q41531069 | Biologically Inspired Smart Release System Based on 3D Bioprinted Perfused Scaffold for Vascularized Tissue Regeneration |
| Q51189575 | Cell-Mediated Proteolytic Release of Growth Factors from Poly(Ethylene Glycol) Matrices. |
| Q51097739 | Chitosan/nHAC/PLGA microsphere vehicle for sustained release of rhBMP-2 and its derived synthetic oligopeptide for bone regeneration. |
| Q41662444 | Controlling Protein Surface Orientation by Strategic Placement of Oligo-Histidine Tags |
| Q41859947 | Development of an angiogenesis-promoting microvesicle-alginate-polycaprolactone composite graft for bone tissue engineering applications |
| Q41348680 | Differential effects of amnion and chorion membrane extracts on osteoblast-like cells due to the different growth factor composition of the extracts |
| Q90481907 | Effects of human urine-derived stem cells on the cementogenic differentiation of indirectly-cocultured periodontal ligament stem cells |
| Q99582639 | Expression optimization, purification and in vitro characterization of human epidermal growth factor produced in Nicotiana benthamiana |
| Q47142933 | Fracture-Targeted Delivery of β-Catenin Agonists via Peptide-Functionalized Nanoparticles Augments Fracture Healing |
| Q89623279 | Growth Factor Engineering Strategies for Regenerative Medicine Applications |
| Q98945388 | Growth Factor and Its Polymer Scaffold-Based Delivery System for Cartilage Tissue Engineering |
| Q41036556 | Hierarchical Fabrication of Engineered Vascularized Bone Biphasic Constructs via Dual 3D Bioprinting: Integrating Regional Bioactive Factors into Architectural Design |
| Q92621873 | Human adipose liquid extract induces angiogenesis and adipogenesis: a novel cell-free therapeutic agent |
| Q41344473 | In Vitro Human Umbilical Vein Endothelial Cells Response to Ionic Dissolution Products from Lithium-Containing 45S5 Bioactive Glass |
| Q59133660 | Increased recruitment of endogenous stem cells and chondrogenic differentiation by a composite scaffold containing bone marrow homing peptide for cartilage regeneration |
| Q49684144 | Integrated approaches to spatiotemporally directing angiogenesis in host and engineered tissues |
| Q47318914 | Leveraging advances in biology to design biomaterials |
| Q38804309 | Local and targeted drug delivery for bone regeneration |
| Q47814370 | Mechanotransduction and Growth Factor Signalling to Engineer Cellular Microenvironments. |
| Q92024513 | PEG grafted chitosan scaffold for dual growth factor delivery for enhanced wound healing |
| Q39032416 | Physical properties and biological interactions of liposomes developed as a drug carrier in the field of regenerative medicine |
| Q100465288 | Preconditioning of surgical pedicle flaps with DNA plasmid expressing hypoxia-inducible factor-1α (HIF-1α) promotes tissue viability |
| Q51027995 | Preparation and characterization of a chitosan/galactosylated hyaluronic acid/heparin scaffold for hepatic tissue engineering. |
| Q90630387 | Role of neurotrophic factors in enhancing linear axonal growth of ganglionic sensory neurons in vitro |
| Q98946051 | Safety and Efficacy of a Novel Antiaging Skin Care Regimen Containing Neutraceuticals and Growth Factors on the Facial Skin of Women: A 12-Week Open-label Study |
| Q55400539 | Stem cells as delivery vehicles for regenerative medicine-challenges and perspectives. |
| Q88422928 | Supramolecular Platform Stabilizing Growth Factors |
| Q38772538 | Synergistic Effects of Vascular Endothelial Growth Factor on Bone Morphogenetic Proteins Induced Bone Formation In Vivo: Influencing Factors and Future Research Directions. |
| Q48313017 | Synergistic growth factor microenvironments. |
| Q89510783 | Systemically Administered, Target-Specific, Multi-Functional Therapeutic Recombinant Proteins in Regenerative Medicine |
| Q93119188 | The Clinical Use of Biologics in the Knee Lesions: Does the Patient Benefit? |
| Q90648008 | The air-liquid interface culture of the mechanically isolated seminiferous tubules embedded in agarose or alginate improves in vitro spermatogenesis at the expense of attenuating their integrity |
| Q48218667 | Tissue Engineering to Improve Immature Testicular Tissue and Cell Transplantation Outcomes: One Step Closer to Fertility Restoration for Prepubertal Boys Exposed to Gonadotoxic Treatments |
Search more.